Colorado Springs, CONCT07577856Now EnrollingIRB Ready

Colitis, Ulcerative Clinical Trial in Colorado Springs, CO

Access cutting-edge colitis, ulcerative treatment through this clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.

Sponsored by Janssen Research & Development, LLC

Quick Self-Assessment

See if you qualify for this Colorado Springs location

Preparing your pre-screening questions…

Expert Care in Colorado Springs

Access colitis, ulcerative specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colitis, ulcerative treatment provided free

Apply for This Colorado Springs Location

Check if you qualify for this colitis, ulcerative clinical trial in Colorado Springs, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Colorado Springs

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Colorado Springs site if eligible
  4. 4Begin participation

About This Colitis, Ulcerative Study in Colorado Springs

The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops ulcers).

Sponsor: Janssen Research & Development, LLC

Who Can Participate

Inclusion Criteria

Diagnosis of ulcerative colitis (UC) established at least 12 weeks before screening including both endoscopic evidence and a histopathology report consistent with a diagnosis of UC.
Moderately to severely active UC defined as baseline (Week 0) modified Mayo score of 5 to 9, inclusive, using the Mayo endoscopy subscore obtained during central review of the screening video endoscopy
An endoscopy subscore \>=2 as obtained during central review of the screening video endoscopy
Have had an inadequate initial response, loss of response, or intolerance to previous approved systemic therapies

Exclusion Criteria

Isolated proctitis (UC limited to the rectum only or to less than \[\<\] 20 centimeter \[cm\] from the anal verge) as determined during central review of the screening video endoscopy OR Has a diagnosis of isolated proctitis
Diagnosis of indeterminate colitis, microscopic colitis, ischemic colitis, Crohn's colitis or any findings suggestive of CD
Has a history of or ongoing chronic or recurrent infectious disease
Has previously demonstrated inadequate initial response, loss of response, allergy, hypersensitivity or intolerance to guselkumab or to golimumab
Is a participant who is pregnant, breastfeeding, or planning to become pregnant, or plans to father a child, while enrolled in this study or within 6 months after the last dose of study intervention

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Colorado Springs?

Yes, this clinical trial (NCT07577856) has an active research site in Colorado Springs, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colitis, Ulcerative Treatment Options in Colorado Springs, CO

If you're searching for colitis, ulcerative treatment options in Colorado Springs, CO, this clinical trial (NCT07577856) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Colorado Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colitis, ulcerative specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colitis, ulcerative clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Colorado Springs, CO

See all rheumatoid arthritis clinical trials recruiting in Colorado Springs — not just this study.

Browse Rheumatoid Arthritis Trials in Colorado Springs →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsUlcerative Colitis TrialsAll Conditions →

Ready to Join in Colorado Springs?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Colorado Springs, CO